Immunological assessment of influenza vaccines and immune correlates of protection (Q38105339)

28 August 2017

Immunological assessment of influenza vaccines and immune correlates of protection (English)

1 reference

28 August 2017

1 reference

1 reference

2

Jacqueline Katz

1 reference

28 August 2017

Adrian Reber

1

1 reference

28 August 2017

1 May 2013

1 reference

Expert Review of Vaccines

28 August 2017

1 reference

28 August 2017

12

1 reference

28 August 2017

519-536

1 reference

28 August 2017

5

1 reference

Seasonal influenza vaccines

28 August 2017

1 reference

The virosomal adjuvanted influenza vaccine

21 January 2018

1 reference

Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine

21 January 2018

1 reference

Report of the fourth meeting on 'Influenza vaccines that induce broad spectrum and long-lasting immune responses', World Health Organization and Wellcome Trust, London, United Kingdom, 9-10 November 2009.

21 January 2018

1 reference

Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets

21 January 2018

1 reference

Nomenclature for immune correlates of protection after vaccination

21 January 2018

1 reference

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

21 January 2018

1 reference

Evaluation of serological trials submitted for annual re-licensure of influenza vaccines to regulatory authorities between 1992 and 2002.

21 January 2018

1 reference

Immune responses to influenza virus infection

21 January 2018

1 reference

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

21 January 2018

1 reference

Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model

21 January 2018

1 reference

Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures

21 January 2018

1 reference

Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children

21 January 2018

1 reference

Antibody recognition of a highly conserved influenza virus epitope

21 January 2018

1 reference

A highly conserved neutralizing epitope on group 2 influenza A viruses

21 January 2018

1 reference

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

21 January 2018

1 reference

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

21 January 2018

1 reference

Influenza virus vaccine based on the conserved hemagglutinin stalk domain

21 January 2018

1 reference

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge

21 January 2018

1 reference

Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies

21 January 2018

1 reference

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

21 January 2018

1 reference

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

21 January 2018

1 reference

Induction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine

21 January 2018

1 reference

Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans

21 January 2018

1 reference

Evaluation of a Neuraminidase-Specific Influenza A Virus Vaccine in Children: Antibody Responses and Effects on Two Successive Outbreaks of Natural Infection

21 January 2018

1 reference

Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection

21 January 2018

1 reference

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity.

21 January 2018

1 reference

Antibody response to the M2 protein of influenza A virus expressed in insect cells

21 January 2018

1 reference

Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2.

21 January 2018

1 reference

Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein

21 January 2018

1 reference

Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses

21 January 2018

1 reference

Prospects for universal influenza virus vaccine

21 January 2018

1 reference

Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets

21 January 2018

1 reference

Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice

21 January 2018

1 reference

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

21 January 2018

1 reference

Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines

21 January 2018

1 reference

Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.

21 January 2018

1 reference

Cross-presentation by dendritic cells

21 January 2018

1 reference

Granzyme B- and Fas ligand-mediated cytotoxic function induced by mitogenic CD28 stimulation of human memory CD4+ T cells

21 January 2018

1 reference

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

Cytotoxic T cells in influenza infection

21 January 2018

1 reference

Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes

21 January 2018

1 reference

Most influenza A virus-specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants

21 January 2018

1 reference

Cytotoxic T-cell immunity to influenza.

21 January 2018

1 reference

Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses

21 January 2018

1 reference

Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.

21 January 2018

1 reference

H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses.

21 January 2018

1 reference

Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

21 January 2018

1 reference

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

21 January 2018

1 reference

Influenza vaccine responses in older adults

21 January 2018

1 reference

Pediatric influenza vaccination: understanding the T-cell response

21 January 2018

1 reference

Vaccination of neonates: problem and issues

21 January 2018

1 reference

Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults

21 January 2018

1 reference

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children

21 January 2018

1 reference

HLA and infectious diseases

21 January 2018

1 reference

The HLA system. First of two parts

21 January 2018

1 reference

Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus

21 January 2018

1 reference

In vivo longitudinal analysis of a dominant TCR repertoire selected in human response to influenza virus

21 January 2018

1 reference

Consistency of HLA associations between two independent measles vaccine cohorts: a replication study

21 January 2018

1 reference

Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination

21 January 2018

1 reference

Human leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: persistence, dampening, and extinction of associations found after a first dose

21 January 2018

1 reference

Identification of an association between HLA class II alleles and low antibody levels after measles immunization

21 January 2018

1 reference

Response to hepatitis B vaccine: multiple HLA genes are involved.

21 January 2018

1 reference

Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine

21 January 2018

1 reference

Serologic assays for influenza surveillance, diagnosis and vaccine evaluation

21 January 2018

1 reference

Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides

21 January 2018

1 reference

Studies on the molecular basis for loss of the ability of recent influenza A (H1N1) virus strains to agglutinate chicken erythrocytes

21 January 2018

1 reference

Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin.

21 January 2018

1 reference

Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine

21 January 2018

1 reference

Measurement of antibodies to avian influenza virus A(H7N7) in humans by hemagglutination inhibition test

21 January 2018

1 reference

Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults

21 January 2018

1 reference

Influenza Virus Subunit Vaccines. II. Immunogenicity and Original Antigenic Sin in Humans

21 January 2018

1 reference

A single radial haemolysis technique for the measurement of influenza antibody

21 January 2018

1 reference

Correlation between Rate of Infection and Preexisting Titer of Serum Antibody as Determined by Single Radial Hemolysis during an Epidemic of Influenza A/Victoria/3/75

21 January 2018

1 reference

Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis

21 January 2018

1 reference

Comparison of influenza serological techniques by international collaborative study.

21 January 2018

1 reference

Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial.

21 January 2018

1 reference

Quantitation and analysis of the specificity of post-immunization antibodies to influenza B viruses using single radial haemolysis

21 January 2018

1 reference

Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study

21 January 2018

1 reference

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

21 January 2018

1 reference

Interference with a conformational change in the haemagglutinin molecule of influenza virus by antibodies as a possible neutralization mechanism

21 January 2018

1 reference

A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine

21 January 2018

1 reference

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

21 January 2018

1 reference

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

21 January 2018

1 reference

Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.

21 January 2018

1 reference

Antibody quantity versus quality after influenza vaccination

21 January 2018

1 reference

A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens

21 January 2018

1 reference

Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates

21 January 2018

1 reference

A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects

21 January 2018

1 reference

Influenza virus-like particles as a new tool for vaccine immunogenicity testing: validation of a neuraminidase neutralizing antibody assay

21 January 2018

1 reference

Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner.

21 January 2018

1 reference

Influenza virus-like particles as pandemic vaccines

21 January 2018

1 reference

The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination

21 January 2018

1 reference

Influenza virus serology--a comparative study

21 January 2018

1 reference

Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.

21 January 2018

1 reference

Increased antibodies against unfolded viral antigens in the elderly after influenza vaccination

21 January 2018

1 reference

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

21 January 2018

1 reference

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.

21 January 2018

1 reference

Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein

21 January 2018

1 reference

Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys

21 January 2018

1 reference

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

21 January 2018

1 reference

Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.

21 January 2018

1 reference

Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1

21 January 2018

1 reference

Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse

21 January 2018

1 reference

Development and evaluation of an M2-293FT cell-based flow cytometric assay for quantification of antibody response to native form of matrix protein 2 of influenza A viruses

21 January 2018

1 reference

Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.

21 January 2018

1 reference

Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus

21 January 2018

1 reference

Control of pathogenic CD4 T cells and lethal immunopathology by signaling immunoadaptor DAP12 during influenza infection

21 January 2018

1 reference

Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects.

21 January 2018

1 reference

Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children

21 January 2018

1 reference

In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses.

21 January 2018

1 reference

A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells.

21 January 2018

1 reference

T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine

21 January 2018

1 reference

Individual antibody and T cell responses to vaccination and infection with the 2009 pandemic swine-origin H1N1 influenza virus

21 January 2018

1 reference

Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor

21 January 2018

1 reference

Cutting edge: contribution of lung-resident T cell proliferation to the overall magnitude of the antigen-specific CD8 T cell response in the lungs following murine influenza virus infection

21 January 2018

1 reference

In vivo proliferation of naïve and memory influenza-specific CD8(+) T cells

21 January 2018

1 reference

Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression

21 January 2018

1 reference

In vitro stimulation of human influenza-specific CD8+ T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine

21 January 2018

1 reference

Transience of MHC Class I-restricted antigen presentation after influenza A virus infection

21 January 2018

1 reference

The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro

21 January 2018

1 reference

Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity.

21 January 2018

1 reference

FL-CTL assay: fluorolysometric determination of cell-mediated cytotoxicity using green fluorescent protein and red fluorescent protein expressing target cells

21 January 2018

1 reference

Influenza circulating strains in Argentina exhibit differential induction of cytotoxicity and caspase-3 in vitro

21 January 2018

1 reference

Use of lactate dehydrogenase to evaluate the anti-viral activity against influenza A virus

21 January 2018

1 reference

FATT-CTL assay for detection of antigen-specific cell-mediated cytotoxicity.

21 January 2018

1 reference

Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial

21 January 2018

1 reference

Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine

21 January 2018

1 reference

Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.

21 January 2018

1 reference

Flow cytometry and the future of vaccine development

21 January 2018

1 reference

Flow cytometric analysis of vaccine responses: how many colors are enough?

21 January 2018

1 reference

Reproducibility of serologic assays for influenza virus A (H5N1).

21 January 2018

1 reference

Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard

21 January 2018

1 reference

Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010.

21 January 2018

1 reference

Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines-an effective EU regulatory approach

21 January 2018

1 reference

Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure.

21 January 2018

1 reference

WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer

21 January 2018

1 reference

Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1-3, 2010.

21 January 2018

1 reference

Influenza vaccines: T-cell responses deserve more attention

21 January 2018

1 reference

FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10–11, 2007

21 January 2018

1 reference

Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells

21 January 2018

1 reference

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies

21 January 2018

1 reference

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans

21 January 2018

1 reference

Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials

21 January 2018

1 reference

Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans

21 January 2018

1 reference

Systems biology of vaccination for seasonal influenza in humans

21 January 2018

1 reference

Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009–2010 Northern Hemisphere season

21 January 2018

1 reference

Personalized vaccines: the emerging field of vaccinomics

21 January 2018

1 reference

The association of class I HLA alleles and antibody levels after a single dose of measles vaccine

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.13.35

1 reference

28 August 2017

1 reference

PubMed ID

23659300